The Management of Maxillary Squamous Cell Carcinoma―A Retrospective Study ()
1. Introduction
Oral cavity cancer is a worldwide problem. There are 263,000 cases each year, which are estimated to cause about 127,000 deaths annually [1] . Squamous cell carcinoma is the predominant neoplastic tumor that occurs in the oral cavity. SCC arising from the maxillary gingiva, hard palate and maxillary alveolus is rare, accounts for approximately 66% of cancers of the hard palate and maxillary alveolus [2] . In these sites, SCC is usually ulcerative and invades the underlying bone in the early stage of the disease. High rates of occult metastasis to the lymph nodes are found in patients with early stage oral cavity cancer, particularly of the oral tongue and floor of mouth [3] - [6] . It is therefore recommended to perform an elective neck dissection in patients with early stage in order to reduce the risk of loco-regional lymph node disease [7] [8] . Due to the rarity of this tumor site, the evolvement of an evidence-based protocol regarding treatment is difficult. In the past, SCC confined to the maxilla was not accompanied by neck dissection, they were felt to have a lower rate of occult regional disease and have been managed by observation of regional lymphatic. Only few data exist in the literature regarding the management of loco-regional lymph nodes and the efficacy of neck dissection or radiation in the clinically negative neck. In recent years, the introduction and evolvement of superior imaging and pathological and molecular techniques has directed a higher occult metastases incidence. Despite the technological progress, no available imaging modality can detect micrometastases. Publications regarding SCC of the maxilla are scarce and management of the clinically negative neck is debatable. Recently higher rates of occult lymph node metastasis are correlated to SCC of the maxillary alveolus and palate [9] - [11] . Surgical elective management of the neck among patients who initially present with no clinical evidence of neck disease has two goals, diagnostic and therapeutic. Elective neck dissection (END) provides crucial information by permitting pathological staging. The END pathological results assist further treatment decisions (a pathohistological positive nodal involvement after supraomohyoid neck dissection will lead to extended neck dissection) and reduce unnecessary radiation, indicating where adjuvant therapy is needed and reduces the need for radical salvage neck dissection as required at the presence of delayed cervical failure [11] . The high rate of cervical nodal disease for T4 SCC supports the recommendation to perform elective neck dissection in patients with N0 [12] - [14] . Elective treatment of the neck in patients with clinically N0 and early stage (T1-2) maxillary SCC remains controversial. In a clinically positive neck, when the cervical lymph nodes are palpable or demonstrated by imaging (CT or MRI) at time of diagnosis, a modified radical neck dissection or radiation therapy is advisable. The aim of the present study is to present our experience regarding elective neck dissection preformed in Squamous cell carcinoma of the maxilla. The aim of the present study is to retrospectively investigate our data regarding maxillary squamous cell carcinoma and establish the role of prophylactic neck dissection in maxillary squamous cell carcinoma.
2. Materials and Methods
The presented study is a retrospective study of archival records of patients that were treated for SCC of the maxillary alveolus, hard palate and gingiva in the Department of Oral and Maxillofacial Surgery at Rambam Medical Center between the years 2000 and 2013. Inclusion criteria were adult patients that were treated for SCC of the maxilla, exclusion criteria; patients with tumors extending to the maxilla from adjacent areas (e.g., maxillary sinus, buccal mucosa and retromolar trigone) or patients with positive metastatatic disease. Initial examination included medical history, physical examination (with thorough head and neck inspection and palpation), blood tests, chest X-ray, electrocardiogram, CT-scan and biopsy. Staging was performed using the criteria for oral cancer developed by the International Union against Cancer (UICC, 2002) TNM classification, based on clinical head and neck examinations and computed tomography scanning. All patients were followed up closely with physical examination. The present work complies with the principles laid down in the Declaration of Helsinki and has been approved by the appropriate ethical committees at our institute.
3. Results
The study group contained 20 patients who met the inclusion criteria, 11 men and 9 women, age of first diagnosis ranged from 40 to 85 years (average 68 years). Table 1 consists of patient characteristics, comprising of age, gender, TNM staging, nodal disease on presentation, presence of nodal metastases on neck dissection pathology and survival. The majority of patients that were diagnosed with occult metastatic disease were either large tumors (T4, 3/5, 60%) or with moderate to poor differentiation (mood-poor 4/5, 80%, 1/5 well-mod, 20%) and all the patients with positive lymph nodes at initial examination were diagnosed with a T4 tumors (Figure 1). All primary tumors were operated on. Two (10%) patients had clinically positive lymph nodes at presentation and received therapeutic neck dissection (selective neck dissection of levels I-IV). The presence of a positive lymph node at initial presentation was determined clinically by palpation or radiographically suspected on CT and fine needle aspiration (FNA) was performed. Eighteen (90%) patients had cN0 (clinically negative nodal involvement) at presentation; four (4/18, 22%) patients did not receive neck dissection either due to refusal by the patient or due to lack mall size (T2) and good cellular differentiation (well differentiation) at the initial biopsy. The rest of the patients, 14, (78%) received an elective supraomohyoid neck dissection (levels I-III). Of the 18 patients with clinically N0 necks, five (28%) had positive neck involvement (pN+) on elective neck dissection, nine (50%) had pathologically negative lymph nodes. One of the patients had a primary resection with no neck treatment, this patient eventually developed metastases in the neck two month postsurgical ablation. This patient was treated with radiotherapy and died seven month later. The calculated occult neck disease is composed of the five pN+ patients (from the initially cN0 group) added to the patient that developed early metastases in the neck,
![]()
Table 1. Patient demographic and clinical data.
cN―Clinical nodal status; pN―Final Pathological nodal status; CRT―Post operative Chemo-radio therapy.
![]()
Figure 1. The distribution of the clinically N0 patients group.
to make an ocuult rate of 33% (6/18). Lymph nodes status distribution in correlation to tumor size is presented in Figure 2 (dark, clinical status, columns represent the sum of striated final pathology columns, Total no. of patients were 20). Patients with positive lymph nodes at presentation (cN+) were all found in T4 tumors. The patient that had a primary resection with no neck treatment and developed early node metastases in the neck had a T2 tumor. Two patients with T2 tumor had pN+ positive lymph nodes on elective neck dissection. Table 2 presents the distribution of lymph nodes status and disease specific death in correlation to tumor size. Seven patients on the T4 group died, 2 patients had a local recurrence, 4 patients had recurrence in neck nodes and 1 patient died of other cause. One patient on the T3 group died from local recurrence. Two patients on the T2 group died, one patient had recurrence in neck nodes and one patient died of other cause.
4. Discussion
The presence or absence of cervical lymph node metastasis is considered to be one of the major prognostic factors for survival in patients with clinically negative cervical lymph nodal involvement at initial examination [15] . The clinical and pathological variables that are associated with the development of cervical lymph node metastasis have been well established in the current literature for other locations like tongue, mouth floor, and cheek [16] - [18] , An incidence of 20% - 30% of cervical metastasis in cancer of the tongue/mouth floor has been found and is well established [16] - [18] . Yet, very few studies have been performed concerning squamous cell carcinoma of the maxilla [11] . Elective treatment of the neck in patients with clinically N0 and early stage (T1-2) maxillary SCC remains debatable due to the relative rarity of cancer of maxillary origin and lack of substantiated large scale publications. Simental et al. (2006) [11] found a 34.6% of cervical metastasis from squamous cell carcinoma of the maxillary alveolus and hard palate. In the present study the overall positive lymph nodes rate was 40% (8/20) with a similar occult metastasis rate of 33% (6/18). Our patients’ disease specific mortality was found to be 45% (9/20). It is well established that high rate of cervical nodal disease is found in large T4 SCC tumors supporting the recommendation to perform elective neck dissection in patients that present with clinically N0 necks [12] - [14] . Recent multicentre studies on the role of neck dissection in maxillary SCC concluded that maxillary SCC exhibits an aggressive metastatic behavior, comparable with that of carcinomas of the tongue, mouth floor, and mandibular gingiva [19] [20] , as a primary management strategy for patients with maxillary squamous-cell carcinomas involving the palate, maxillary gingiva, or maxillary alveolus the Beltramini et al. and the Montes et al groups recommended selective neck dissection in all patients with T2-T4 tumors and clinically negative necks. The majority of our patients that were diagnosed with occult metastatic disease were either large tumors (T4, 3/5, 60%) or high grade with moderate to poor differentiation (mood-poor 4/5, 80%, 1/5 well-mod, 20%), these results support the current literature in the need for neck treatment in advanced SCC of the maxilla (T2-T4) but also in high grade cases with moderate-poorly cellular differentiation. It is well
![]()
Table 2. Distribution of lymph node status and disease specific death in correlation to tumorsize.
![]()
cN0―No clinical nodal; cN+―Positive node at initial examination; pN0―No Pathological nodal; pN+―Positive pathological Nodes; No ND―No neck dissection performed.
Figure 2. Lymph nodes status with correlation to the maxillary tumor size.
known that a 15% to 20% incidence of lymph node metastases is considered the accepted threshold for elective neck dissection in other, more prevalent, sites of oral SCC [21] - [23] .
5. Conclusion
The results presented in this study support recent publications from the multicentric groups from 2011-2012 [19] [20] and also with previous results published by Kruse and Grätz from 2009 [9] . Regarding the presented results, the main limitation of our study is the relatively low number of patients. Nevertheless, when considering the rarity of maxillary SCC, the high rate of cervical involvement is 40%; which is considered above the accepted threshold for elective neck dissection. 25% of the T2 maxillary SCC patients have cervical nodal involvement. We feel that it is well accepted that T2 and greater maxillary SCC or high grade cellular differentiation carcinomas with a N0 neck should receive a selective (I-III) neck dissection as a part of their oncological treatment. Future large scale prospective trials are needed to establish guidelines for maxillary squamous cell carcinoma treatment.
Competing Interests
The authors declare that they have no competing interests.
NOTES
*Corresponding author.